{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T02:29:46Z","timestamp":1794450586225,"version":"4.9.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273785"],"award-info":[{"award-number":["82273785"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8227378"],"award-info":[{"award-number":["8227378"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119214","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:42:02Z","timestamp":1786376522000},"page":"119214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of benzoisonicotinamide derivatives as novel xanthine oxidase inhibitors guided by metabolic stability"],"prefix":"10.1016","volume":"319","author":[{"given":"Gong-hui","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-feng","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-han","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan-hao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2700-5683","authenticated-orcid":false,"given":"Ting-jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119214_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fmed.2018.00160","article-title":"Physiology of hyperuricemia and urate-lowering treatments","volume":"5","author":"Benn","year":"2018","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119214_bib2","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.1038\/s41598-020-65639-0","article-title":"Association between serum copper levels and prevalence of hyperuricemia: a cross-sectional study","volume":"10","author":"Jiang","year":"2020","journal-title":"Sci. Rep."},{"issue":"10287","key":"10.1016\/j.ejmech.2026.119214_bib3","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119214_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118459","article-title":"Benzoheterocyclic analogues of dotinurad as orally efficacious human urate transporter 1 inhibitors: design, synthesis, structure-activity relationships, and pharmacokinetic studies","volume":"303","author":"Zhang","year":"2026","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119214_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4078\/jrd.2024.0054","article-title":"The pathogenesis of gout","volume":"32","author":"Ahn","year":"2025","journal-title":"J Rheum Dis"},{"issue":"7","key":"10.1016\/j.ejmech.2026.119214_bib6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","article-title":"Pathogenesis of gout","volume":"143","author":"Choi","year":"2005","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119214_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/rheumatology\/ket329","article-title":"Bone erosions in patients with chronic gouty arthropathy are associated with tophi but not bone oedema or synovitis: new insights from a 3 T MRI study","volume":"53","author":"McQueen","year":"2014","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119214_bib8","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.molmed.2017.06.005","article-title":"Molecular pathophysiology of gout","volume":"23","author":"Desai","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejmech.2026.119214_bib9","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.12659\/MSM.899852","article-title":"Hyperuricemia-related diseases and xanthine oxidoreductase (XOR) inhibitors: an overview","volume":"22","author":"Chen","year":"2016","journal-title":"Med. Sci. Monit."},{"issue":"23","key":"10.1016\/j.ejmech.2026.119214_bib10","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.ejmech.2026.119214_bib11","doi-asserted-by":"crossref","first-page":"10723","DOI":"10.1073\/pnas.97.20.10723","article-title":"Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: Structure-based mechanism of conversion","volume":"97","author":"Enroth","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119214_bib12","first-page":"323","article-title":"Purification and immunohistochemical tissue localization of human xanthine oxidase","volume":"1164","author":"Moriwaki","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"issue":"36","key":"10.1016\/j.ejmech.2026.119214_bib13","doi-asserted-by":"crossref","first-page":"28044","DOI":"10.1074\/jbc.M110.128561","article-title":"Substrate orientation and catalytic specificity in the action of xanthine oxidase: the sequential hydroxylation of hypoxanthine to uric acid","volume":"285","author":"Cao","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119214_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106394","article-title":"Anti-gout activity and the interaction mechanisms between Sanghuangporus vaninii active components and xanthine oxidase","volume":"133","author":"Song","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119214_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bioorg.2018.04.021","article-title":"Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles","volume":"79","author":"Fatima","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119214_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/0929867023371229","article-title":"Progress towards the discovery of xanthine oxidase inhibitors","volume":"9","author":"Borges","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119214_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bioorg.2014.08.007","article-title":"Synthesis and xanthine oxidase inhibitory activity of 5,6-dihydropyrazolo\/pyrazolo[1,5-c]quinazoline derivatives","volume":"57","author":"Kumar","year":"2014","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119214_bib18","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.ejmech.2011.01.043","article-title":"Antioxidant xanthone derivatives induce cell cycle arrest and apoptosis and enhance cell death induced by cisplatin in NTUB1 cells associated with ROS","volume":"46","author":"Cheng","year":"2011","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119214_bib19","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1517\/13543776.2011.577417","article-title":"Xanthine oxidase inhibitors: a patent survey","volume":"21","author":"Kumar","year":"2011","journal-title":"Expert Opin. Ther. Pat."},{"issue":"24","key":"10.1016\/j.ejmech.2026.119214_bib20","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.1016\/j.bmcl.2012.10.029","article-title":"Isocytosine-based inhibitors of xanthine oxidase: design, synthesis, SAR, PK and in vivo efficacy in rat model of hyperuricemia","volume":"22","author":"Khanna","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119214_bib21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3109\/0886022X.2014.882240","article-title":"Circulating purine compounds, uric acid, and xanthine oxidase\/dehydrogenase relationship in essential hypertension and end stage renal disease","volume":"36","author":"Boban","year":"2014","journal-title":"Ren. Fail."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119214_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12872-018-0757-9","article-title":"Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Bredemeier","year":"2018","journal-title":"BMC Cardiovasc. Disord."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119214_bib23","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119214_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/pr.58.1.6","article-title":"Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119214_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-198611050-00001","article-title":"Clinical pharmacokinetics of allopurinol","volume":"11","author":"Murrell","year":"1986","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2026.119214_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109481","article-title":"Discovery of 1-(4-cyanopyrimidin-2-yl)-1H-pyrazole-4-carboxylic acids as potent xanthine oxidase inhibitors via molecular cleavage and reassembly of allopurinol as a key strategy","volume":"170","author":"Wang","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119214_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109076","article-title":"Design, synthesis, and evaluation of N-substituted indolyl-diazine derivatives as potent xanthine oxidase inhibitors","volume":"166","author":"Li","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119214_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109279","article-title":"Synthesis and biological evaluation of genipin derivatives as novel xanthine oxidase inhibitors for the anti-hyperuricemia and hepatorenal protection activity","volume":"167","author":"Sun","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119214_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106064","article-title":"A possible covalent xanthine oxidase inhibitor TS10: inhibition mechanism, metabolites identification and PDPK assessment","volume":"128","author":"Zhang","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119214_bib30","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1016\/j.bmc.2012.03.019","article-title":"Identification of novel isocytosine derivatives as xanthine oxidase inhibitors from a set of virtual screening hits","volume":"20","author":"B-Rao","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119214_bib31","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.bmcl.2014.01.050","article-title":"HTS followed by NMR based counterscreening. Discovery and optimization of pyrimidones as reversible and competitive inhibitors of xanthine oxidase","volume":"24","author":"Even\u00e4s","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"37","key":"10.1016\/j.ejmech.2026.119214_bib32","doi-asserted-by":"crossref","first-page":"10138","DOI":"10.1021\/jp105062c","article-title":"Tautomerism in cytosine and uracil: a theoretical and experimental X-ray absorption and resonant auger study","volume":"114","author":"Feyer","year":"2010","journal-title":"J. Phys. Chem. A"},{"issue":"7","key":"10.1016\/j.ejmech.2026.119214_bib33","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ardp.201400031","article-title":"4,6-Diaryl\/heteroarylpyrimidin-2(1H)-ones as a new class of xanthine oxidase inhibitors","volume":"347","author":"Shukla","year":"2014","journal-title":"Arch. Pharm. (Weinheim)"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119214_bib34","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1124\/jpet.104.070433","article-title":"Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic acid]: a potent xanthine oxidoreductase inhibitor with hepatic excretion","volume":"311","author":"Fukunari","year":"2004","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119214_bib35","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0960-894X(01)00093-2","article-title":"Synthesis and structure\u2013activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors","volume":"11","author":"Ishibuchi","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119214_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejmech.2017.08.047","article-title":"Synthesis and bioevaluation of 1-phenyl-pyrazole-4-carboxylic acid derivatives as potent xanthine oxidoreductase inhibitors","volume":"140","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119214_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111883","article-title":"Synthesis and bioevaluation of 1-phenylimidazole-4-carboxylic acid derivatives as novel xanthine oxidoreductase inhibitors","volume":"186","author":"Zhou","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119214_bib38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejmech.2015.08.056","article-title":"Synthesis and evaluation of 1-hydroxy\/methoxy-4-methyl-2-phenyl-1H-imidazole-5-carboxylic acid derivatives as non-purine xanthine oxidase inhibitors","volume":"103","author":"Chen","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119214_bib39","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ejmech.2018.01.060","article-title":"Design, synthesis and biological evaluation of 1-hydroxy-2-phenyl-4-pyridyl-1H-imidazole derivatives as xanthine oxidase inhibitors","volume":"146","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119214_bib40","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bmcl.2015.01.055","article-title":"Design and synthesis of novel 2-(indol-5-yl)thiazole derivatives as xanthine oxidase inhibitors","volume":"25","author":"Song","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119214_bib41","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1021\/acs.jmedchem.3c00205","article-title":"Discovery and optimization of novel biphenyl derivatives bearing cyclopropyl linkage as potent programmed cell death-1\/programmed cell death-ligand 1 inhibitors","volume":"66","author":"Jing","year":"2023","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2026.119214_bib42","doi-asserted-by":"crossref","first-page":"16687","DOI":"10.1021\/acs.jmedchem.1c01422","article-title":"Design, synthesis, and pharmacological evaluation of biaryl-containing PD-1\/PD-L1 interaction inhibitors bearing a unique difluoromethyleneoxy linkage","volume":"64","author":"Song","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119214_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.pscia.2024.100039","article-title":"WN1703 alleviates gout symptoms via inflammatory signaling pathways in an acute gout rat model","volume":"2","author":"Liu","year":"2024","journal-title":"Pharm Sci Adv"},{"key":"10.1016\/j.ejmech.2026.119214_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118213","article-title":"Piperidine-containing drugs and recently studied analogs \u2013 biological activity, mechanism of action and synthetic cascade access to their scaffolds","volume":"302","author":"\u0141owicki","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119214_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105938","article-title":"Design, synthesis and biological evaluation of N-(4-alkoxy-3-(1H-tetrazol-1-yl)phenyl) heterocyclic aromatic amide derivatives as xanthine oxidase inhibitors","volume":"127","author":"Zhang","year":"2022","journal-title":"Bioorg. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:01:21Z","timestamp":1793977281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426006598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":45,"alternative-id":["S0223523426006598"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119214","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of benzoisonicotinamide derivatives as novel xanthine oxidase inhibitors guided by metabolic stability","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119214"}}